Published in Drug Alcohol Depend on March 07, 2008
An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med (2011) 2.06
Cognition, commitment language, and behavioral change among cocaine-dependent patients. Psychol Addict Behav (2008) 1.72
Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev (2012) 1.67
Cognitive enhancement as a treatment for drug addictions. Neuropharmacology (2012) 1.54
Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav (2011) 1.00
Relationship of cognitive function and the acquisition of coping skills in computer assisted treatment for substance use disorders. Drug Alcohol Depend (2010) 0.98
Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia. Drug Alcohol Depend (2009) 0.94
Cognitive function as an emerging treatment target for marijuana addiction. Exp Clin Psychopharmacol (2010) 0.90
HealthCall for the smartphone: technology enhancement of brief intervention in HIV alcohol dependent patients. Addict Sci Clin Pract (2014) 0.85
Failure to sustain prepulse inhibition in adolescent marijuana users. Drug Alcohol Depend (2010) 0.85
New developments in behavioral treatments for substance use disorders. Curr Psychiatry Rep (2013) 0.77
Mediated and moderated effects of neurocognitive impairment on outcomes of treatment for substance dependence and major depression. J Consult Clin Psychol (2014) 0.76
Effects of yohimbine and drug cues on impulsivity and attention in cocaine-dependent men and women and sex-matched controls. Drug Alcohol Depend (2016) 0.75
Self-reported Cognitive Scales in a U.S. National Survey: Reliability, Validity, and Preliminary Evidence for Associations with Alcohol and Drug Use. Addiction (2017) 0.75
The effects of synthetic cannabinoids on executive function. Psychopharmacology (Berl) (2017) 0.75
Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA (2004) 6.60
Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA (2002) 6.48
The residual cognitive effects of heavy marijuana use in college students. JAMA (1996) 4.28
Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry (2001) 3.27
Dose-related neurocognitive effects of marijuana use. Neurology (2002) 3.25
One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch Gen Psychiatry (1994) 3.20
Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend (2005) 2.66
A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry (2002) 2.64
Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend (2003) 2.10
The Marijuana Treatment Project: rationale, design and participant characteristics. Addiction (2002) 1.94
Long-term heavy marijuana users make costly decisions on a gambling task. Drug Alcohol Depend (2004) 1.60
Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry (1995) 1.27
Substance abuse treatment outcomes for cognitively impaired and intact outpatients. Addict Behav (2002) 1.21
Cognitive correlates of long-term cannabis use in Costa Rican men. Arch Gen Psychiatry (1996) 1.18
Response perseveration and adaptation in heavy marijuana-smoking adolescents. Addict Behav (2006) 1.16
Attributes of long-term heavy cannabis users: a case-control study. Psychol Med (2003) 1.11
Effects of executive function impairment on change processes and substance use outcomes in 12-step treatment. J Stud Alcohol (1999) 1.11
Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. J Psychopharmacol (2006) 1.10
Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry (2004) 8.45
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet (2011) 6.35
Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry (2004) 4.81
Immigration and lifetime prevalence of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry (2004) 4.73
Socio-economic status and problem alcohol use: the positive relationship between income and the DSM-IV alcohol abuse diagnosis. Addiction (2008) 3.63
The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2005) 3.53
Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population. Drug Alcohol Depend (2007) 3.52
Mental health of college students and their non-college-attending peers: results from the National Epidemiologic Study on Alcohol and Related Conditions. Arch Gen Psychiatry (2008) 3.52
Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs. Psychiatr Serv (2007) 3.38
State-level policies and psychiatric morbidity in lesbian, gay, and bisexual populations. Am J Public Health (2009) 3.20
Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2005) 3.20
Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry (2008) 3.15
The impact of institutional discrimination on psychiatric disorders in lesbian, gay, and bisexual populations: a prospective study. Am J Public Health (2010) 3.13
Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2006) 3.06
Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med (2005) 3.04
The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2006) 2.96
Adolescent marijuana use from 2002 to 2008: higher in states with medical marijuana laws, cause still unclear. Ann Epidemiol (2011) 2.81
Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial. J Acquir Immune Defic Syndr (2008) 2.78
Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend (2005) 2.66
Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug Alcohol Depend (2007) 2.63
Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction (2011) 2.58
Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions. J Psychiatr Res (2005) 2.47
Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Bipolar Disord (2012) 2.47
Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network. Am J Psychiatry (2009) 2.44
Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol (2009) 2.26
Childhood maltreatment and the structure of common psychiatric disorders. Br J Psychiatry (2011) 2.21
Organizational Readiness for Change and opinions toward treatment innovations. J Subst Abuse Treat (2007) 2.14
Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend (2010) 2.10
Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addiction (2010) 1.99
An invariant dimensional liability model of gender differences in mental disorder prevalence: evidence from a national sample. J Abnorm Psychol (2011) 1.95
Risk factors for long-term homelessness: findings from a longitudinal study of first-time homeless single adults. Am J Public Health (2005) 1.88
DSM-IV alcohol dependence and abuse: further evidence of validity in the general population. Drug Alcohol Depend (2006) 1.86
Stressful life experiences, alcohol consumption, and alcohol use disorders: the epidemiologic evidence for four main types of stressors. Psychopharmacology (Berl) (2011) 1.83
Sex differences in subclinical and DSM-IV pathological gambling: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med (2006) 1.79
Birth cohort effects and gender differences in alcohol epidemiology: a review and synthesis. Alcohol Clin Exp Res (2011) 1.77
Cognition, commitment language, and behavioral change among cocaine-dependent patients. Psychol Addict Behav (2008) 1.72
Predictors of psychosis remission in psychotic disorders that co-occur with substance use. Schizophr Bull (2006) 1.67
Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug Alcohol Depend (2007) 1.64
Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness. Addiction (2013) 1.63
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend (2011) 1.62
Smoking cessation treatment in community-based substance abuse rehabilitation programs. J Subst Abuse Treat (2007) 1.57
Genomewide suggestive linkage of opioid dependence to chromosome 14q. Hum Mol Genet (2007) 1.54
The DSM-5 field trials and reliability of alcohol use disorder. Am J Psychiatry (2013) 1.48
Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial. Am J Drug Alcohol Abuse (2011) 1.44
Changes in cigarette use and nicotine dependence in the United States: evidence from the 2001-2002 wave of the national epidemiologic survey of alcoholism and related conditions. Am J Public Health (2008) 1.43
Telescoping and gender differences in alcohol dependence: new evidence from two national surveys. Am J Psychiatry (2010) 1.42
Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatry (2014) 1.40
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry (2008) 1.39
Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials (2011) 1.38
Racial/ethnic disparities in service utilization for individuals with co-occurring mental health and substance use disorders in the general population: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry (2008) 1.37
Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. Am J Psychiatry (2011) 1.37
Behavioral naltrexone therapy: an integrated treatment for opiate dependence. J Subst Abuse Treat (2002) 1.36
Service utilization differences for Axis I psychiatric and substance use disorders between white and black adults. Psychiatr Serv (2008) 1.35
Child physical abuse and adult mental health: a national study. J Trauma Stress (2012) 1.33
Regularly Drinking Alcohol Before Sexual Activity in a Nationally Representative Sample: Prevalence, Sociodemographics, and Associations With Psychiatric and Substance Use Disorders. Am J Public Health (2015) 1.32
A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend (2005) 1.31
Adverse childhood events and lifetime alcohol dependence. Am J Public Health (2008) 1.31
Errors in assessing DSM-IV substance use disorders. Arch Gen Psychiatry (2007) 1.31
Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry (2010) 1.29
The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA Clinical Trials Network "Women and trauma" multi-site study. AIDS Behav (2009) 1.28
Influence of a drinking quantity and frequency measure on the prevalence and demographic correlates of DSM-IV alcohol dependence. Alcohol Clin Exp Res (2009) 1.28
Generalizability of clinical trials for alcohol dependence to community samples. Drug Alcohol Depend (2008) 1.25
Associations between perceived weight discrimination and the prevalence of psychiatric disorders in the general population. Obesity (Silver Spring) (2009) 1.25
Commentary on Harper S, Strumpf EC, Kaufman JS. Do medical marijuana laws increase marijuana use? Replication study and extension. Ann Epidemiol (2012) 1.23
Suicide attempts in substance abusers: effects of major depression in relation to substance use disorders. Am J Psychiatry (2002) 1.23
Prevalence, correlates, disability, and comorbidity of DSM-IV schizotypal personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. Prim Care Companion J Clin Psychiatry (2009) 1.23
Sedative use and misuse in the United States. Addiction (2002) 1.21
Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch Gen Psychiatry (2005) 1.19
Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial. Biol Psychiatry (2012) 1.18
Violent behavior and DSM-IV psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry (2008) 1.18
Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend (2005) 1.18
The structure and predictive validity of the internalizing disorders. J Abnorm Psychol (2012) 1.17
Childhood or adolescent parental divorce/separation, parental history of alcohol problems, and offspring lifetime alcohol dependence. Drug Alcohol Depend (2008) 1.17
Health-related quality of life across the anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions (NESARC). J Clin Psychiatry (2010) 1.16
Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2008) 1.13
Adult transition from at-risk drinking to alcohol dependence: the relationship of family history and drinking motives. Alcohol Clin Exp Res (2008) 1.12
Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial. Am J Addict (2006) 1.11
Management of relapse in naltrexone maintenance for heroin dependence. Drug Alcohol Depend (2007) 1.11
Psychiatric comorbidity and the persistence of drug use disorders in the United States. Addiction (2012) 1.10
Mapping common psychiatric disorders: structure and predictive validity in the national epidemiologic survey on alcohol and related conditions. JAMA Psychiatry (2013) 1.10
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry (2011) 1.10
Substance use and high risk sexual behaviors among women in psychosocial outpatient and methadone maintenance treatment programs. Am J Drug Alcohol Abuse (2009) 1.09
Attentional bias towards cocaine-related stimuli: relationship to treatment-seeking for cocaine dependence. Am J Drug Alcohol Abuse (2007) 1.09
Relationship power and sexual risk among women in community-based substance abuse treatment. J Urban Health (2009) 1.07
Gender, HIV status, and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2011) 1.07
Assessing addiction: concepts and instruments. Addict Sci Clin Pract (2007) 1.06
Utility of lead-in period in cocaine dependence pharmacotherapy trials. Drug Alcohol Depend (2005) 1.06
Providing live supervision via teleconferencing improves acquisition of motivational interviewing skills after workshop attendance. Am J Drug Alcohol Abuse (2007) 1.05
Comorbidity of generalized anxiety disorder and substance use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2010) 1.04
Epidemiology of major depression with atypical features: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry (2011) 1.04